Expression of cornifin in squamous differentiating epithelial tissues, including psoriatic and retinoic acid-treated skin.
The expression of cornifin, a putative cross-linked envelope precursor, was investigated in several squamous differentiating tissues by in situ hybridization and immunohistochemical analysis. Cornifin mRNA and protein, which are absent in the normal mucociliary tracheal epithelium, are induced in the suprabasal layers of the squamous metaplastic tracheal epithelium of vitamin A-deficient hamsters. Similar to the induction of squamous metaplasia in vivo, culture of rabbit tracheal cells in the absence of retinoids results in squamous differentiation and expression of cornifin. This induction of cornifin expression is suppressed by retinoic acid and several of its analogs. Cornifin mRNA and protein are also detected in the suprabasal layers of the squamous epithelium of rabbit esophagus and tongue. The distribution of cornifin in human epidermis was compared with that of two other crosslinked envelope precursor proteins, involucrin and loricrin. The localization of cornifin and involucrin is very similar. Both are induced in the spinous layer and appear at an earlier stage during epidermal differentiation than loricrin. The expression of cornifin is greatly increased in psoriatic skin. Cornifin mRNA is barely detectable in normal epidermis, whereas it is present at relatively high levels in the suprabasal layers of psoriatic epidermis. Topical treatment with RA results in thickening of the skin and increases the level of cornifin mRNA and protein in the upper spinous layers of mouse skin. Cornifin expression correlates generally with squamous differentiation in a variety of tissues and is abnormally regulated in psoriatic skin and in skin treated topically with retinoic acid.
Cell Biology Section, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709.
W
W
Fujimoto
K W
KW
Marvin
M D
MD
George
G
G
Celli
N
N
Darwiche
L M
LM
De Luca
A M
AM
Jetten
D000287:Administration, Topical; D000818:Animals; D002478:Cells, Cultured; D055233:Cornified Envelope Proline-Rich Proteins; D006224:Cricetinae; D004947:Esophagus / Q000737:chemistry; D015870:Gene Expression; D006801:Humans; D008297:Male; D008565:Membrane Proteins / Q000032:analysis / Q000235:genetics*; D051379:Mice; D011498:Protein Precursors / Q000032:analysis; D011565:Psoriasis / Q000473:pathology*; D012333:RNA, Messenger / Q000032:analysis; D011817:Rabbits; D012867:Skin / Q000187:drug effects*; D014132:Trachea / Q000737:chemistry; D014134:Tracheal Neoplasms / Q000473:pathology; D014212:Tretinoin / Q000494:pharmacology*; D014802:Vitamin A Deficiency / Q000378:metabolism
D055233:Cornified Envelope Proline-Rich Proteins; D008565:Membrane Proteins; D011498:Protein Precursors; D012333:RNA, Messenger; C064554:loricrin; D014212:Tretinoin; C032253:involucrin